Logo image of BALY

BALLY'S CORP (BALY) Stock Fundamental Analysis

NYSE:BALY - New York Stock Exchange, Inc. - US05875B3042 - Common Stock - Currency: USD

10.08  +0.75 (+8.04%)

After market: 10 -0.08 (-0.79%)

Fundamental Rating

2

Taking everything into account, BALY scores 2 out of 10 in our fundamental rating. BALY was compared to 134 industry peers in the Hotels, Restaurants & Leisure industry. Both the profitability and financial health of BALY have multiple concerns. BALY is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

BALY had negative earnings in the past year.
BALY had a positive operating cash flow in the past year.
In the past 5 years BALY always reported negative net income.
Each year in the past 5 years BALY had a positive operating cash flow.
BALY Yearly Net Income VS EBIT VS OCF VS FCFBALY Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M -400M

1.2 Ratios

BALY has a worse Return On Assets (-5.48%) than 77.61% of its industry peers.
The Return On Equity of BALY (-51.52%) is worse than 64.93% of its industry peers.
The Return On Invested Capital of BALY (0.61%) is worse than 76.87% of its industry peers.
Industry RankSector Rank
ROA -5.48%
ROE -51.52%
ROIC 0.61%
ROA(3y)-6.39%
ROA(5y)-4.24%
ROE(3y)-639.86%
ROE(5y)-385.68%
ROIC(3y)N/A
ROIC(5y)N/A
BALY Yearly ROA, ROE, ROICBALY Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -500 -1K -1.5K

1.3 Margins

BALY's Operating Margin of 2.15% is on the low side compared to the rest of the industry. BALY is outperformed by 74.63% of its industry peers.
Looking at the Gross Margin, with a value of 54.32%, BALY is in the better half of the industry, outperforming 64.18% of the companies in the same industry.
BALY's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 2.15%
PM (TTM) N/A
GM 54.32%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.11%
GM growth 5Y-3.47%
BALY Yearly Profit, Operating, Gross MarginsBALY Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 60

More info and screens

0

2. Health

2.1 Basic Checks

BALY has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for BALY has been increased compared to 1 year ago.
The number of shares outstanding for BALY has been increased compared to 5 years ago.
BALY has a worse debt/assets ratio than last year.
BALY Yearly Shares OutstandingBALY Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
BALY Yearly Total Debt VS Total AssetsBALY Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

2.2 Solvency

BALY has an Altman-Z score of 0.37. This is a bad value and indicates that BALY is not financially healthy and even has some risk of bankruptcy.
BALY's Altman-Z score of 0.37 is on the low side compared to the rest of the industry. BALY is outperformed by 79.10% of its industry peers.
A Debt/Equity ratio of 4.31 is on the high side and indicates that BALY has dependencies on debt financing.
Looking at the Debt to Equity ratio, with a value of 4.31, BALY is doing worse than 60.45% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 4.31
Debt/FCF N/A
Altman-Z 0.37
ROIC/WACC0.07
WACC8.21%
BALY Yearly LT Debt VS Equity VS FCFBALY Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B

2.3 Liquidity

A Current Ratio of 0.75 indicates that BALY may have some problems paying its short term obligations.
With a Current ratio value of 0.75, BALY perfoms like the industry average, outperforming 41.79% of the companies in the same industry.
A Quick Ratio of 0.72 indicates that BALY may have some problems paying its short term obligations.
BALY has a Quick ratio (0.72) which is in line with its industry peers.
Industry RankSector Rank
Current Ratio 0.75
Quick Ratio 0.72
BALY Yearly Current Assets VS Current LiabilitesBALY Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

More info and screens

4

3. Growth

3.1 Past

BALY shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -13.94%.
Looking at the last year, BALY shows a decrease in Revenue. The Revenue has decreased by -1.93% in the last year.
BALY shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 36.16% yearly.
EPS 1Y (TTM)-13.94%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%86.7%
Revenue 1Y (TTM)-1.93%
Revenue growth 3Y22.83%
Revenue growth 5Y36.16%
Sales Q2Q%-4.74%

3.2 Future

The Earnings Per Share is expected to grow by 24.00% on average over the next years. This is a very strong growth
BALY is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 5.81% yearly.
EPS Next Y85.87%
EPS Next 2Y39.07%
EPS Next 3Y24%
EPS Next 5YN/A
Revenue Next Year2.71%
Revenue Next 2Y4.58%
Revenue Next 3Y5.81%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
BALY Yearly Revenue VS EstimatesBALY Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 500M 1B 1.5B 2B 2.5B
BALY Yearly EPS VS EstimatesBALY Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 -2 -4 -6 -8 -10

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

BALY reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year BALY is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
BALY Price Earnings VS Forward Price EarningsBALY Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, BALY is valued a bit cheaper than 60.45% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 10.93
BALY Per share dataBALY EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 -20 40 -40

4.3 Compensation for Growth

A more expensive valuation may be justified as BALY's earnings are expected to grow with 24.00% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y39.07%
EPS Next 3Y24%

More info and screens

0

5. Dividend

5.1 Amount

BALY does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

BALLY'S CORP

NYSE:BALY (6/18/2025, 8:04:00 PM)

After market: 10 -0.08 (-0.79%)

10.08

+0.75 (+8.04%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Services
GICS IndustryHotels, Restaurants & Leisure
Earnings (Last)05-12 2025-05-12/amc
Earnings (Next)07-29 2025-07-29/bmo
Inst Owners79.52%
Inst Owner Change48.37%
Ins Owners2.47%
Ins Owner Change-7.4%
Market Cap494.02M
Analysts50.91
Price Target15.15 (50.3%)
Short Float %0.24%
Short Ratio1.82
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-84.59%
Min EPS beat(2)-187.58%
Max EPS beat(2)18.41%
EPS beat(4)2
Avg EPS beat(4)-729.87%
Min EPS beat(4)-2765.33%
Max EPS beat(4)18.41%
EPS beat(8)2
Avg EPS beat(8)-615.91%
EPS beat(12)3
Avg EPS beat(12)-718.81%
EPS beat(16)4
Avg EPS beat(16)-567.8%
Revenue beat(2)0
Avg Revenue beat(2)-3.84%
Min Revenue beat(2)-4.31%
Max Revenue beat(2)-3.37%
Revenue beat(4)0
Avg Revenue beat(4)-4.56%
Min Revenue beat(4)-5.87%
Max Revenue beat(4)-3.37%
Revenue beat(8)0
Avg Revenue beat(8)-3.74%
Revenue beat(12)0
Avg Revenue beat(12)-3.75%
Revenue beat(16)1
Avg Revenue beat(16)-3.7%
PT rev (1m)-8.62%
PT rev (3m)-13.77%
EPS NQ rev (1m)20.15%
EPS NQ rev (3m)46.23%
EPS NY rev (1m)0%
EPS NY rev (3m)30.84%
Revenue NQ rev (1m)0.72%
Revenue NQ rev (3m)5.94%
Revenue NY rev (1m)0.16%
Revenue NY rev (3m)3.33%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.2
P/FCF N/A
P/OCF 5.9
P/B 0.62
P/tB N/A
EV/EBITDA 10.93
EPS(TTM)-8.58
EYN/A
EPS(NY)-0.77
Fwd EYN/A
FCF(TTM)-3.7
FCFYN/A
OCF(TTM)1.71
OCFY16.94%
SpS49.4
BVpS16.25
TBVpS-56.58
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -5.48%
ROE -51.52%
ROCE 0.77%
ROIC 0.61%
ROICexc 0.63%
ROICexgc 1.39%
OM 2.15%
PM (TTM) N/A
GM 54.32%
FCFM N/A
ROA(3y)-6.39%
ROA(5y)-4.24%
ROE(3y)-639.86%
ROE(5y)-385.68%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.11%
GM growth 5Y-3.47%
F-Score6
Asset Turnover0.32
Health
Industry RankSector Rank
Debt/Equity 4.31
Debt/FCF N/A
Debt/EBITDA 10.04
Cap/Depr 91.53%
Cap/Sales 10.95%
Interest Coverage 0.18
Cash Conversion 24.49%
Profit Quality N/A
Current Ratio 0.75
Quick Ratio 0.72
Altman-Z 0.37
F-Score6
WACC8.21%
ROIC/WACC0.07
Cap/Depr(3y)125.58%
Cap/Depr(5y)105.92%
Cap/Sales(3y)17.68%
Cap/Sales(5y)13.89%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-13.94%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%86.7%
EPS Next Y85.87%
EPS Next 2Y39.07%
EPS Next 3Y24%
EPS Next 5YN/A
Revenue 1Y (TTM)-1.93%
Revenue growth 3Y22.83%
Revenue growth 5Y36.16%
Sales Q2Q%-4.74%
Revenue Next Year2.71%
Revenue Next 2Y4.58%
Revenue Next 3Y5.81%
Revenue Next 5YN/A
EBIT growth 1Y147.82%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year413.88%
EBIT Next 3Y75.17%
EBIT Next 5YN/A
FCF growth 1Y28.32%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-64.09%
OCF growth 3Y11.25%
OCF growth 5Y3.91%